Here's What to Look for in Moderna's Upcoming Earnings Report
Hot demand for vaccine doses might start cooling soon.
Moderna Inc.(MRNA)
Nasdaq Global Select
MRNA
$345.74
-$3.82
-1.1%
Price as of October 26, 2021, 4:00 p.m. ET
View Interactive MRNA Charts
Moderna Inc.
Interactive Chart
Compare MRNA Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
MRNA
Moderna Inc.
|
$345.74 | $141B | 397.7% | |
|
ILMN |
$417.19 | $66B | 31.9% | 200.7% |
|
EXEL |
$21.66 | $7B | -1.2% | 93.5% |
|
GILD |
$67.73 | $85B | 17.8% | 7.0% |
|
BMY |
$58.24 | $128B | -0.0% | 36.1% |
News & Analysis: Moderna Inc.
The Fool has written over 900 articles on Moderna Inc..
Why Moderna Stock Surged Today
The vaccine maker announced two promising developments.
How Low Can Moderna Stock Go?
It's a tough question to answer. But here's a stab at it.
Could Moderna Stock Help You Retire a Millionaire?
More blockbusters may be in Moderna's future.
Why Moderna Stock Is Falling Today
Deutsche Bank initiated coverage on the vaccine stock with a sell rating.
Here's Why Moderna's Growth May Be Just Getting Started
The company's COVID-19 vaccine might have set the stage for something big.
3 Biotech Stocks That Are Ridiculously Overpriced
They've risen too far, too quickly.
Why Moderna Stock Is Rising Today
There's a super-bullish estimate for Moderna's 2022 sales.
Is Moderna a Good Healthcare Stock to Buy Now?
The vaccine maker has a promising pipeline but an expensive valuation.
Could Moderna Justify Its $129 Billion Valuation?
The company's COVID-19 vaccine has been a massive success, but how much is the underlying technology worth?
